Acrux Ltd (ACR)

Sydney
0.115
-0.005(-4.17%)
  • Volume:
    44,551
  • Bid/Ask:
    0.115/0.120
  • Day's Range:
    0.115 - 0.118

ACR Overview

Prev. Close
0.12
Day's Range
0.115-0.118
Revenue
4.79M
Open
0.118
52 wk Range
0.115-0.32
EPS
-0.06
Volume
44,551
Market Cap
34.04M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
208,466
P/E Ratio
-
Beta
1.03
1-Year Change
-35%
Shares Outstanding
283,680,338
Next Earnings Date
30 Nov 2021
What is your sentiment on Acrux Ltd?
or
Vote to see community's results!

Acrux Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Acrux Ltd Company Profile

Acrux Ltd Company Profile

Employees
43
Market
Australia

Acrux Limited is an Australia-based pharmaceutical company. The Company is engaged in developing and commercializing a portfolio of generic topical prescription pharmaceutical products which use dermal and transdermal drug delivery technology. The Company's product pipeline includes Evamist, Lenzetto, Jublia, EMLA and Testosterone Topical Solution. The Company's transdermal or topical pharmaceutical product portfolio can be segregated into approximately two streams, such as generic pharmaceutical products and specialty pharmaceutical products. The products offered by the Company are the testosterone topical solution to treat adult males who have low or no testosterone and Estradiol MDTS to treat moderate to severe hot flushes commonly associated with menopause. It is also developing a range of topical and dermatological generic products for the United States market. The Company operates in the United States, Europe and other markets.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.